Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Pancreatic Neoplasms × Interviews as Topic × Clear all

Status

Withdrawn 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 22 Prostatic Neoplasms 10 Breast Neoplasms 10 Colorectal Neoplasms 9 Ovarian Neoplasms 6 Lung Neoplasms 5 Hematologic Neoplasms 4 Advanced Cancer 4 Uterine Cervical Neoplasms 3 Rectal Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Multiple Myeloma 3 Lymphoma 3 Head and Neck Neoplasms 3 Gastrointestinal Neoplasms 3 Pain 2 Mouth Neoplasms 2 Low Anterior Resection Syndrome 2 Fatigue 2 Endometrial Neoplasms 2 Depression 2 Colonic Neoplasms 2 Brain Neoplasms 2 Bone Neoplasms 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Total Exenteration 1 Tobacco Use Cessation 1 Thyroid Neoplasms 1 Stomach Neoplasms 1

Interventions

Gemcitabine 328 Fluorouracil 84 Oxaliplatin 70 Capecitabine 66 Albumin-Bound Paclitaxel 64 Radiotherapy 62 130-nm albumin-bound paclitaxel 61 Leucovorin 52 Erlotinib Hydrochloride 46 Irinotecan 45 Cisplatin 43 Bevacizumab 30 Radiosurgery 29 pembrolizumab 25 Docetaxel 25 Taxes 23 Nivolumab 23 Cetuximab 20 Pancreaticoduodenectomy 17 Cyclophosphamide 15 Radiation 13 Drug Therapy 13 folfirinox 12 Endoscopic Ultrasound-Guided Fine Needle Aspiration 12 irinotecan sucrosofate 11 Sorafenib 11 S 1 (combination) 11 Paclitaxel 11 Neoadjuvant Therapy 11 Ipilimumab 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04257955 2023-10-31

COMMUNICARE

IRCCS San Raffaele

Gastrointestinal

Disease, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡